Briacell Therapeutics Corp BCTXW

Primary Symbol: T.BCT Alternate Symbol(s): BCTX

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp > BCTX To Quickly Regain $8/share

<< Previous

Bullboard Posts

Next >>

Comment by LondonInveston Jul 06, 2022 11:05am

153 Views

Post# 34804957

RE:RE:RE:BCTX To Quickly Regain $8/share

I agree, but the 200-DMA is only a slight decline and I like how BCTX is tugging on the 50-DMA pulling it back up. Chart looks like it has a ton of potential on weekly chart. Could have real legs. I am expecting the whole biotech sector to start getting bid up in size. We will see. I have my position and it is quite news dependent. Day to day doesn't matter much (it is a roller coaster), but if they deliver these gyrations won't show up in a chart in the future. GL

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario